<DOC>
	<DOC>NCT00852462</DOC>
	<brief_summary>The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).</brief_summary>
	<brief_title>Lung Cancer Symptom Assessment and Management Intervention</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>HCPs: attending physician, thoracic medical oncologist, expected to work in the setting for at least 2 years. Patients: 21 years of age or older; diagnosis of Stage IIIA, IIIB, IV nonsmall cell lung cancer OR limited or extensive stage small cell lung cancer; receiving care in the outpatient setting; receiving treatment with chemotherapy +/ additional therapies; English speaking. Patients: Any patient who needs emergent care, routine visits scheduled less than once a month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>SAMI</keyword>
	<keyword>Symptom Assessment and Management Intervention Program</keyword>
</DOC>